Telavancin Pharmacokinetics in Cystic Fibrosis Patients
NCT03172793
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
Telavancin Injection
Sponsor
Joseph L. Kuti, PharmD
Collaborators
[object Object]